CTOs on the Move

Afferent Pharmaceuticals

www.afferentpharma.com

 
Afferent Pharmaceuticals, Inc. is a leader in the development of novel, selective drugs for the treatment of a range of debilitating neurogenic disorders. These disorders affect millions of patients who suffer from chronic respiratory and urologic sensory pathologies as well as chronic pain, and who have limited, if any, treatment options. These chronic disorders arise when certain nerve fibers become hyper-sensitized as a result of inflammation, distress, infection or tissue injury, and sometimes remain chronically sensitized for months or even years.
  • Number of Employees: 0-25
  • Annual Revenue: $0-1 Million

Executives

Name Title Contact Details

Funding

Afferent Pharmaceuticals raised $55M on 07/08/2015

Similar Companies

Tekmira Pharma

Tekmira Pharmaceuticals Corporation is a biopharmaceutical company focused on advancing novel RNAi therapeutics and providing its leading lipid nanoparticle delivery technology to pharmaceutical partners. Tekmira has been working in the field of nucleic acid delivery for over a decade and has broad intellectual property covering LNPs. Further information about Tekmira can be found at www.tekmirapharm.com. Tekmira is based in Vancouver, B.C.

The California Poison Control System (CPCS)

The California Poison Control System (CPCS) is a San Francisco, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Aspenbio Pharma Inc

Aspenbio Pharma Inc is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Castle Rock, CO. To find more information about Aspenbio Pharma Inc, please visit www.aspenbiopharma.com

Toniiq

Toniiq (pronounced "tonic") is the answer to the ineffective and bland hangover treatments available today. It is made exclusively from a single natural ingredient, and unlike other products, does not contain dozens of additives or fillers. Our obsessi...

Cancer Expert Now

Cancer Expert Now`s services connect you to distinguished experts to discuss current disease challenges, recent literature, global clinical findings, and even share their research and experience in the context of your specific diagnosis, or patient cases.